Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: SAMSUNG BIOEPIS CO., LTD
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02522829 | SAMSUNG BIOEPIS CO., LTD | AYBINTIO | Human | Yes | Prescription Recommended | 1 | BEVACIZUMAB | 100 MG / 4 ML |
Marketed | 02522829 | SAMSUNG BIOEPIS CO., LTD | AYBINTIO | Human | Yes | Schedule D | 1 | BEVACIZUMAB | 100 MG / 4 ML |
Marketed | 02522837 | SAMSUNG BIOEPIS CO., LTD | AYBINTIO | Human | Yes | Prescription Recommended | 1 | BEVACIZUMAB | 400 MG / 16 ML |
Marketed | 02522837 | SAMSUNG BIOEPIS CO., LTD | AYBINTIO | Human | Yes | Schedule D | 1 | BEVACIZUMAB | 400 MG / 16 ML |
Marketed | 02455323 | SAMSUNG BIOEPIS CO., LTD | BRENZYS | Human | Yes | Prescription | 1 | ETANERCEPT | 50 MG / ML |
Marketed | 02455323 | SAMSUNG BIOEPIS CO., LTD | BRENZYS | Human | Yes | Schedule D | 1 | ETANERCEPT | 50 MG / ML |
Marketed | 02455331 | SAMSUNG BIOEPIS CO., LTD | BRENZYS | Human | Yes | Schedule D | 1 | ETANERCEPT | 50 MG / ML |
Marketed | 02455331 | SAMSUNG BIOEPIS CO., LTD | BRENZYS | Human | Yes | Prescription | 1 | ETANERCEPT | 50 MG / ML |
Marketed | 02525852 | SAMSUNG BIOEPIS CO., LTD | BYOOVIZ | Human | Yes | Schedule D | 1 | RANIBIZUMAB | 10 MG / ML |
Marketed | 02525852 | SAMSUNG BIOEPIS CO., LTD | BYOOVIZ | Human | Yes | Prescription | 1 | RANIBIZUMAB | 10 MG / ML |
Marketed | 02473097 | SAMSUNG BIOEPIS CO., LTD | HADLIMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02473097 | SAMSUNG BIOEPIS CO., LTD | HADLIMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02533472 | SAMSUNG BIOEPIS CO., LTD | HADLIMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02533472 | SAMSUNG BIOEPIS CO., LTD | HADLIMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02473100 | SAMSUNG BIOEPIS CO., LTD | HADLIMA PUSHTOUCH | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02473100 | SAMSUNG BIOEPIS CO., LTD | HADLIMA PUSHTOUCH | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02533480 | SAMSUNG BIOEPIS CO., LTD | HADLIMA PUSHTOUCH | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02533480 | SAMSUNG BIOEPIS CO., LTD | HADLIMA PUSHTOUCH | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02524317 | SAMSUNG BIOEPIS CO., LTD | ONTRUZANT | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02524317 | SAMSUNG BIOEPIS CO., LTD | ONTRUZANT | Human | Yes | Prescription | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02524325 | SAMSUNG BIOEPIS CO., LTD | ONTRUZANT | Human | Yes | Prescription | 1 | TRASTUZUMAB | 440 MG / VIAL |
Marketed | 02524325 | SAMSUNG BIOEPIS CO., LTD | ONTRUZANT | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 440 MG / VIAL |
Approved | 02550539 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Approved | 02550539 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Approved | 02550547 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
Approved | 02550547 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
Approved | 02550520 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA I.V. | Human | Yes | Schedule D | 1 | USTEKINUMAB | 5 MG / ML |
Approved | 02550520 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA I.V. | Human | Yes | Prescription | 1 | USTEKINUMAB | 5 MG / ML |
Marketed | 02470373 | SAMSUNG BIOEPIS CO., LTD | RENFLEXIS | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Marketed | 02470373 | SAMSUNG BIOEPIS CO., LTD | RENFLEXIS | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Application information
Related information
Contact us
Version 4.0.3